Cargando…
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients
CONTEXT: The management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge. Short-term studies suggest an interest in the use of medical cannabis, but long-term data are lacking. OBJECTIVES: The objective of this study was to investigate the feasibility...
Autores principales: | Pautex, Sophie, Bianchi, Federica, Daali, Youssef, Augsburger, Marc, de Saussure, Christian, Wampfler, James, Curtin, François, Desmeules, Jules, Broers, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557769/ https://www.ncbi.nlm.nih.gov/pubmed/36247984 http://dx.doi.org/10.3389/fnagi.2022.957665 |
Ejemplares similares
-
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol
por: Bianchi, Federica, et al.
Publicado: (2023) -
Erratum: Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients
Publicado: (2023) -
Patient-Related Barriers to the Prescription of Cannabinoid-Based Medicines in Palliative Care: A Qualitative Approach
por: Kalonji, Pauline, et al.
Publicado: (2022) -
Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions
por: Storelli, Flavia, et al.
Publicado: (2019) -
Semantic dementia Brazilian study of nineteen cases
por: Senaha, Mirna Lie Hosogi, et al.
Publicado: (2007)